We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms and Conditions of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here we highlight some ETFs from the house of ARK Investment Management that have gained more than 100% in the past year for our investors to consider.
genetics: Archive
Bear of the Day: CRISPR Therapeutics (CRSP)
by Kevin Cook
Gene editors got a big boost recently from sickle cell potential and Cathie Wood's thematic investing
CRSPNegative Net Change EDITNegative Net Change ARKKNegative Net Change NTLANegative Net Change ARKGNegative Net Change
biofuels cancer genetics genomics medical
Bear of the Day: Illumina (ILMN)
by Kevin Cook
Maker of premier next-gen genomic sequencing technology lowers guidance but shares make new highs
ILMNNegative Net Change EDITNegative Net Change NVTANegative Net Change ARKKNegative Net Change ARKGNegative Net Change
biotechs coronavirus genetics genomics
5 Top-Performing ARK ETFs Worth Your Attention Now
by Sweta Jaiswal, FRM
Here we highlight some ETFs from the house of ARK Investment Management that have gained more than 100% in the past year for our investors to consider.
TDOCNegative Net Change PYPLNegative Net Change SQNegative Net Change ARKQNegative Net Change ARKWNegative Net Change ARKKNegative Net Change CRSPNegative Net Change ROKUNegative Net Change ARKGNegative Net Change GBTCNegative Net Change ARKFNegative Net Change
cloud-computing e-commerce etfs genetics internet
Bull of the Day: Meridian Bioscience (VIVO)
by Kevin Cook
Small-cap diagnostics player will grow sales 20%+ to over $310 million on COVID-19 testing and its mutations
VIVONegative Net Change HOLXNegative Net Change QDELNegative Net Change EDITNegative Net Change CRSPNegative Net Change
coronavirus genetics genomics medical
The Innovative Future Of ETFs
by Daniel Laboe
Ark Invest is driving a new generation of actively managed ETFs
TSLANegative Net Change SQNegative Net Change ROKUNegative Net Change PRLBNegative Net Change NVTANegative Net Change CRSPNegative Net Change ARKKNegative Net Change
biotechs etfs genetics software tech-stocks
Genomics ETFs Surge on Nobel Prize for Gene-Editing Pioneers
by Sweta Jaiswal, FRM
The announcement of the 2020 Nobel Prize winners for Chemistry has successfully brought investor attention to the gene-editing space.
PBENegative Net Change ARKGNegative Net Change GNOMNegative Net Change IDNANegative Net Change
etfs genetics
Bear of the Day: Illumina (ILMN)
by Madeleine Johnson
The coronavirus pandemic has dampened this medical stock's earnings and outlook.
TMONegative Net Change ILMNNegative Net Change
genetics genomics
Bull of the Day: Quidel (QDEL)
by Kevin Cook
Multiple FDA approvals for new 15-minute COVID-19 antigen tests have estimates and shares rising sharply
QDELNegative Net Change MRNAPositive Net Change
biotechs genetics medical
Profit from the Genomics Market Momentum With These ETFs
by Sweta Jaiswal, FRM
Here we highlight some ETFs for gaining exposure to the genomics market that is currently buzzing with opportunities for investors to cash on.
GSKNegative Net Change PBENegative Net Change ARKGNegative Net Change GNOMNegative Net Change IDNANegative Net Change
etfs genetics
Bull of the Day: Vertex Pharma (VRTX)
by Kevin Cook
While COVID-19 interrupts clinical trials, the champ of cystic fibrosis is about to repeat another year of 37% revenue growth
VRTXNegative Net Change CRSPNegative Net Change
biotechs genetics genomics medical pharmaceuticals